Skip to main content
. 2022 Dec 9;8(49):eadd3599. doi: 10.1126/sciadv.add3599

Fig. 5. In vivo study on inhibiting tumor recurrence after surgery.

Fig. 5.

(A) Schematic representation of the therapy schedule in a 4T1 tumor recurrence mouse model. (B) Representative bioluminescence images of 4T1 tumor recurrence in mice. (C and D) Individual (C) and average (D) recurrent tumor growth kinetics in different treatment groups as indicated (n = 6 biologically independent mice per group). (E) Survival curves for mice (n = 6 biologically independent mice per group). (F) Weight of recurrent tumors collected from mice (n = 4 biologically independent mice per group). Statistical significance was calculated by two-way ANOVA with a Tukey post hoc test for (D), log-rank (Mantel-Cox) test for (E), or one-way ANOVA with a Tukey post hoc test for (F).